Abstract
We report the synthesis and characterization of a series of enantiopure 5-cyclopropane-bearing pyridyldiazabicyclo[3.3.0]octanes that display low nanomolar binding affinities and act as functional agonists at α4β2-nicotinic acetylcholine receptor (nAChR) subtype. Structure-activity relationship studies revealed that incorporation of a cyclopropane-containing side chain at the 5-position of the pyridine ring provides ligands with improved subtype selectivity for nAChR β2 subunit-containing nAChR subtypes (β2∗-nAChRs) over α4∗-nAChRs compared to the parent compound 4. Compound 15 exhibited subnanomolar binding affinity for α4β2-and α4β2∗-nAChRs with negligible interaction. Functional assays confirm selectivity for α4β2-nAChRs. Furthermore, using the SmartCube assay system, this ligand showed antidepressant, anxiolytic, and antipsychotic features, while mouse forced-swim assay further confirm the antidepressant-like property of 15.
Original language | English (US) |
---|---|
Pages (from-to) | 1196-1201 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 5 |
Issue number | 11 |
DOIs | |
State | Published - Nov 13 2014 |
Keywords
- N-pyridyldiazabicyclo[3.3.0]octane
- Nicotinic acetylcholine receptor
- selective α4β2 partial agonist
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry